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w1 Tuberculous otornastoiditis causing a facial apy The high resistance rates to penicillin usually ruggect the addi- 
tion of a glycopeptide in the treatment of related infections. Palsy 
E. Palenque, C. Bolafios, S. Perea. Hospital 12 de Octubre, Madrid, 
Spairi /p997] Spectrum of bloodstream infections in a 
department of hematology. Do Gram-positive 
bacteria still dominate? Case report: Tuberculous middle otitis is an exceptional disease. 
Diagnosis is usually delayed (particularly in children) due to the lack . . -  
of signs and syinptoms. We herein report a case of a 6-year-old child 
with no previous family antecedents of tuberculosis whose otomas- 
toiditis started with a left-side peripheral facial palsy 3 days before 
hospital admittance. The patient had no other otologic Fymptoiiis 
(otalgia, otorrhea). Chest X-ray film was normal. CAT-scan showed 
total occupation of the tympanic cavity encapsulating the ossicles and 
mastoid cavity 
The tympanic meinbrane and contents ofthe inner ear were surgi- 
cally removed. No discharge was seen during surgery. 
Histopathology showed granulomas with epithelioid and multin- 
uclear giant cells. After surgery, facial palsy subsided totally, with 
simultaneous appearance of purulent discharge which was sent for 
niicrobiological study. 
Stains (bacteria and mycobacteria) were negative. 
Purified protein derivative skin test was positive in the child and 
his mother. Consequently, prophylaxis with isoniazid was started, 
followed 2 weeks later with rifainpim and pirazinamide, because 
susceptible M ~ m h a r t e r i n ~ n  f benirlosis had been cultured. 
Dircharge disappeared after a week of treatment, and 3 months 
later the audiogram showed a significant hearing loss (68 a). 
lmmunocompromised host 
(p9961 Viridans streptococci bacteremia in 
neutropenic children with cancer 
J. Sinko, E. Ban. Central Hospitalfor Inzctiotts Diswccs ‘Loszb’, 
Budapesf, Hiriipry 
The etiology of bloodstream infections was analyzed, focusing on 
results found in 1996 and 1998. The blood cultures were procwed 
by the BacTAlert (Organon Teknika) system using nrrobic, anaci-o- 
bic and FAN blood culture media. The types of infection\ can be 
characterized on a clinical basit as follows: blood\ti-eaiii infections 
29%, microbiologically documented infections 2% clinically docii- 
inented infections 16% and fever of unknown origin 53%. In the 
spectrum of bloodstream infections in 1996 there wac ail absolute 
dominance of Gram-positive bacteria (64%) followed by (;ram-negd- 
tive rods and yeasts (34% and 2%, respectively). In contract t o  resultr 
found in 1996, the spectrum of bacteria shifted towards the Gram- 
negative direction in 1998, comprising 54%) of all microbcs icolared. 
Among the Gram-negative rods we identified quite iniucnal ctmins. 
The antimicrobial resistance of the bacteria isolated froni blood was 
also analyzed; some trends need further clarification. Our study calls 
attention to the possible resurgence of Gram-neptivc bacteria in 
infections of imniunocoinpromised hosts. 
lp998) Infectious complications in patients (pts) with 
hematologic malignancies (HM) 
N. Bagirova. Canrev Research Ccnfer, bfosroiq Russia 
Objectives: To determine the basic pathogens in tepsis, pneumonia 
and urinary tract infections in pts with HM. 
Methods: A survey of serious infections in hospitalized cidult ptc 
(352) was undertaken between January 1990 and September 1998 in 
our clinic, and included 756 isolates from blood, respiratory tract, and 
urine. 
Results: Sepsis causative factors were mainly Gram-positive cocci 
I. Paraskakis’, A. Pourtsidis’, M. Tsirepa’, G. Stamos’, H. 
Kotmidis’. Deparfnients qf ‘Microbiology and 20ncolo~y,  ‘I? G A .  
K~wiakorr’ Childreti ‘s Hospital, Ahens, Greece 
Objectives: To evaluate the episodes of viridans streptococci 
bactereinia docuinented in children with cancer hospitalized over a 
7-year period (1991-97) a t  the Oncology Department ofa Children‘s 
hospital. 
Methods: Organisms were isolated with a broth-based system and 
were identified by the API 20 Strep system (BioMerieux, France). 
The antimicrobial susceptibility was assessed by the Etest method. 
Results: Viridans streptococci were isolated from 8 children, 
accounting for 5.1% of 157 bacteremic cases identified during this 
period. Steptococcal strains were identified as S. inifis 5, S.  sangnis 2 
and S. ai?,@iiosits 1. Three patierits suffered from solid tumors and 5 
from leukemia or lymphoma. All patients presented with fever 
(=38.3”C) during the profound neutropenic phase following an 
intensive multidrug chemothei-apy regimen, while 4 had severe 
gingivitis, 1 gingival bleeding, 1 perianal lesions and 1 soft tissue 
infection. Six children were on co-trimoxazole prophylaxis. 
Coniplications were observed in 3 cases; 1 developed shock, 1 devel- 
oped coma and 1 died. The isolxes exhibited resistance to penicillin 
(75%) and to erythromycin (62.5%), while all were susceptible to 
cefotaxime, clindainycin, vancomycin and teicoplanin. All but one 
child recovcred after a 14-day 171 course of vancomycin. 
Conclusions: Viridans streptococci have been a major problem 
in neutropenic patients treated with intensive inultidrug cheniother- 
(50%) (Staphylococcus epidrrmidis accounting for 34’%, Stu~~hylocuc~-trs 
aweus for 8% and Streptococcus spp. for 8%). Gram-negative bacilli 
were isolated in 18 cases (Klebsiella pnertnioriia 6% E. coli 4% and 
Pseudornorias acnqinora 3%. Fungi were isolated iii 14% of caw.  
Candida albirans represented up to 11% of the bloodstream pathogens 
identified in HM, and was much more frequent than Carrdida non- 
albirarrs and mold 07<0.002). The same pathogen was isolated cimul- 
taneously from blood and from removed central venour catheters i n  
43% ofpts. Pneumonia causative factors were mainly fungi (41%) and 
Candida albicans (26%). Yeast was isolated more often than mold 
(p < 0.0001). Fungi were isolated significantly more often than 
Gram-potitive cocci (3196, p<O.01) and Grain-negat~ve bacilli (20‘XL 
p < 0.0001). Urinary tract infection causative factors werc entero- 
cocci (24% E. coli, 16% Candida albitans). 
Conclusions: The results of this trial denionstratc that the 
predominant pathogens in H M  were Grain-positive cocci (37%)) and 
fungi (34%). Gram-negative bacilli were isolated vgnificantly less 
often than Gram-positive cocci and fungi (21% p<O.OOOl). 
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(p999] Epidemiology of bacteremia in a hematology 
unit in France 
S. Vacher’, J. Fourche’, M. Boiron’, P.H. Agape’, J. Reiffers’, J. 
Maugein’ . ’Laboratory .f BacterioloB, ’Hematology Unit, CHU 
Bordeaux, France 
The aim of this study was to describe the microbiological parameters 
in patients with febrile neutropenia. Information came from blood 
cultures collected in the hematology unit of the Hbpital Haut 
Levique, Bordeaux, France, from 1991 to 1998. 
There was a shift from Gram-negative (38% in 1991; 21% in 1998) 
to Gram-positive pathogens (46% in 1991; 57% in 1998). Aerobic 
organisms (Pseudomonas, Acinetobacter) increased until 1995 and then 
returned to their initial levels. The frequency of Gram-positive infec- 
tions was higher in neutropenic patients who had received oral 
antibiotherapy for a digestive tract decontamination (65% versus 
40%). Conversely, bacteremia due to enterobacteria was more 
frequent in those who had not (41% versus 10%). 
Over the last 2 years, the methicillin resistance of staphylococci 
isolated from blood samples has increased slightly (23% in 1996 versus 
28% in 1998 for S. aureus; 58% in 1996 versus 64% in 1998 for coag- 
ulase-negative staphylococci). All the strains of Stuphyloroccus isolated 
since 1996 have been susceptible to vancomycin, and 15% of CNS 
have been of intermediate susceptibility to teicoplanin. Concerning 
enterobacteria, no resistance to cefepime and cefpirome was 
observed, despite extensive use of these molecules during this period. 
Some strains hyperproducing cephalosporinase (8%) were resistant to 
ceftazidime. Amikacin was better than tobramycin (96% versus 88% 
ofstrains susceptible). In 1998, the most effective B-lactamines against 
Pseudomonas were ceftazidime and imipenem (83%), followed by 
cefepime (80%). Amikacin and tobramycin had similar activity, with 
85% of strains being susceptible. 
Over the last few years, despite extensive use of the fourth-gener- 
ation cephalosporins, no resistant strain emergence has been 
observed. 
Ip1ooo1 Infectious complications after high-dose 
chemotherapy and autologous stem cell 
transplantation 
G. Reich, M.Y. Mapara, B.Dorken, G. Maschmeyer. Department of 
Hematology and Oncology, Charite Robert-R-ssle-Klinik, Humboldt- 
University, Berlin, Germany 
Objectives: We studied the incidence, type and severity of infec- 
tious complications after autologous stem cell transplantation. 
Methods: We retrospectively analysed the infections complica- 
tions of 117 patients (14 multiple myeloma, 1 akute leukemia, 36 
lymphoma, 66 solid tumors) who received 178 cycles of high-dose 
chemotherapy and autologous stem cell transplantations from 
November 1994 to May 1998 at a single institute. 
Results: The median duration of neutropenia (<0,5 WBC/nl ) 
was 8 days. The incidence of fever was 63%. 35,4% of patients had 
fever of unknown orign (FUO). Bacteremia occured in in 21.3% of 
patients, pneumonia in 3,4%, severe skin infections in l , l%.  1 patient 
developed a severe enterocolitis, and 3 invasive fungal infections were 
observed. Infection was fatal in 3 patients who died from septic shock 
during neutropenia. The most common pathogen organism were 
gram-positive cocci. Median time to defervescence under antimicrobial 
therapy was 4 days (6 days in patients with bacteremia or severe infec- 
tions, and 3 days in patients with FUO). We observed a better 
response to the first-line antimicrobial therapy in the patients with 
FUO (65%) compared to the patients with documented infections 
(30,6%). Analysing the incidence, epidemiology and clinical course 
of their infectious complications, no differences between patients 
with hematologic nialignacies or solid tumors could be detected. 
Conclusions: Further prospective, randomised studies have to be 
done to identify low- and high-risk groups with respect to infectious 
complications 
Spectrum of surveillance cultures and 
infections after 652 different solid organ (SO) 
and 133 stem cell (SC) transplants (TI: what 
is common, what is different? 
H. Bonatti, D. Nachbauer, R. Kafka, G. Kropshofer, C. Angerer, J. 
Bodner, H. Antretter, W Tabarelli, G. Muhlmann, L. Mullet, D. 
Niedenvieser, K. Margreiter. University Hospital Innsbmck, 
Innsbmck, Austria 
Objectives: Infection remains the most common complication in 
transplantation medicine (solid organ (SO) as well as stem cell (SC)) 
during the early posttransplant period. Clinical data from 785 trans- 
plant patients undergoinig SO/SC transplantation at our hospital 
were analysed with regard to infectious complications. 
Methods: 46364 microbioiogical specimens (mean 71 /patients 
(PP)) taken on 25396 (median 34 (range 6-161) PP) observation days 
(d), of which were d on antibiotics (incl. prophylaxis) 80%, pyrexial 
d 38% were retrospectively analysed. 
Results: 11 46 infectious episodes (1,46 PP) were observed with 
a median incidence of UTI (2096, pancreaticT 47%), pneumonia 
(14%, lungT29%), sepsis (lo%, SCT 20%), HSV (24%, SCT30%), 
CMV (IS%, lungT:41%). Torgan kidney pancreas liver heart lung 
stem cell n (T) 252 94 207 82 17 133 study period 94-97 87-96 87- 
96 93-98 93-96 83-94 age 46 37 46 56 52 32 rejection/GvH 42% 
74% 48% 35% 53% 35% lysurvival 97% 92% 85% 80% 80% 60% 
specimens/T 23 69 73 39 72 109 sterile 37% 53% 59% 56% 48% 44% 
normal flora 32% 19% 7% 13% 18% 34%1 pathogens 36% 28% 34% 
31% 34% 22% Gram+cocci 35% 44% 57% 58% 56% 68% Gram- 
bacilli 48% 31% 22% 22% 15% 7% non-ferm. bac 5% 7% 11% 2% 
15% 3% fungi 12% 16% 10% 17% 13% 20% Highly resistent 
pathogens: Coryneybacterium JK/Stenotrophomonas/Burgholderi 
0,l%, E. faecium 3%. MRSA 6%, MRCNS 7%. 
Conclusions: In terms of infections SO/SC recipients should not 
be put together and simply called transplant patient. Individual strate- 
gies should be worked out and optimised according to lokal factors, 
patient demographics and immunosuppression. 
The outcome of inappropriately treated 
febrile cancer patients with bacteremia 
S. Spanik, D. West, P. Pichna, J. Novotny, J. Dacok, M. Mraz, 
B. Chmelik, I .  Krupova, V. Krcmery Jr. Clinical Medicine and 
Clinical Pharmaco/ogy, Znava University, Enava, Slovak Republic 
Objectives: The aim of the present study was to asses the outconie 
of inappropriately treated cancer patients with documented bacteremia. 
Methods: 95 cases of inappropriately treated bacteremias in 
febrile cancer patients were analyzed and compared with a group of 
appropriately treated bacteremias to assess risk &tors for inappro- 
priate therapy and outcome. 
Results: Among 285 bacteremias, 95 (33,3 %) were not treated 
appropriately, with 42 receiving the wrong antibiotics and 17 having 
too short a therapeutic course of appropriate antibiotics. In 13, ther- 
apy was delayed for more than 48 hours after onset of fever. Twenty- 
three patients did not receive antibiotic therapy at all despite 
bacteremia. A group of 95 inappropriately treated bacteremias was 
compared to 190 appropriately treated bacteremias occuring in the 
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same period. Microbiological cure after the initial course of therapy 
was achieved more often (76,8 o/o vs 38,9 %, P<.O01) in the group 
of appropriately treated bacteremias and also in the subgroup of 
leukemic patients (P<.O1). 
Conclusions: Inappropriately treated bacteremic cancer patients 
had outcomes that were significantly worse than patients who were 
treated appropriately. 
m] Sepsis related 1:o central venous catheter in 
children with ciincer 
G. Dotti', R. Marinoni', 1. Gardini', G. De Intinis', C. Scolfaro', 
C. Riva', M.  Giachmo'. 'Department vf Clinicaal Patliolopx Regina 
Maylierira Children 's Hospital, 'Department vf Pediatrics, University of 
Turin, X)rinu, Italy 
Category: 9: Infection in the unniunocompmmised host (except 
HIV) 
Objectives: To estimate the prevalence of central venous catheters 
(C.V.C.) sepsis in children affected by cancer 
Methods: Blood cultures were simultaneously perfornied using 
samples obtained from the catether and the peripheral vein in onco- 
logic children with fever from January the 1st 1996 to October the 
31th 1998. We used Bactalert system for cultures. 
Results: From 1996 to 1998 we documented 217 cases ofsepsis 
in children affected hy cancer, 38 cases were related to central venous 
catheter. The organisms isolated were 23 Gram positive cocci 
(60.5%), 11 Gram negative bacilli (29.0%), 4 fungi (10.5%): 12 
coagulase negative Staphilococcus, 8 Streptococcus iiiitis, 3 
Staphilococcus aureus, 4 Pseudonionas species, 3 Klebsiella oxytoca, 
3 Aciiietobacter lowifti, 1 Cartdida parapsilosis, 1 Candida guillcr- 
mondii, 2 Aspergillus fuiiiigatus 
Conclusions: The prevalence of C.V.C. related sepsis was lower 
than previously reported in tht: literature; however we observed a 
significant increase of C.V.C. related bacteriemias due to Gram nega- 
tives. 
Im Central venous catheter (CVC) infections in 
patients with acute leukemia 
M. Karthaus, T. Dbllinann, C. Elser, T. Klimasch, G. Heil, A. 
Ganser. Departmcnt vf Hematology arid OncoloXy, Hurznover Medical 
Sr'rhool, Hannover, Gemzany 
Objectives: CVC-related infections are known origin of nosoco- 
niial infections. Data regarding the incidence are rare In pts with 
acute leukaemia and neutropenia (< 500/pl). 
Methods: We analysed uiitimneled CVC m 58 pts with acute 
leukaemia (22 m/36 0 within 119 chemotherapy cycles from 4/96 
to 1/98. Proven CVC-related infection was the isolation ofthe same 
organism from peripheral blood and CVC-tip. CVC-infection was 
suspicious resp. possible when exit-site inflammation and pas. blood 
culture resp. organirnis typical for CVC-infection were observed. 
Results: Mean neutropenidcycle was 16,7 days (SD 7,7). 178 
CVC with 2576 CVC days (mean 14,5d, SD 7,2d) were used in 119 
cycles. Fever occurred in 87 cycles (73%). Bloodstream infection was 
proven in 31 out 87 eps (26,1%) with 40 isolates (8 gram-neg, 31 
gram pas, 1 candida ssp.). Coloniisation of the CVC-tip was observed 
in 24 CVC-lines with 28 isolates (27 gram-pos., 1 graiii-neg.), 
however, proven CVC-related infections were observed in 5 eps only, 
all with coag.-pos. Staphylococci. In another 6 eps CVC-related 
infection was assumed (local inflammation and gram-pos. blood 
culture). Six further eps had typical isolates (4 coag-pos staphylo- 
cocci, 1 Candida ssp) from the blood and were considered possible 
CVC related infections. In none of the remaining afebrile 32 cycles 
a CVC- infection was observed or suspected. 
Conclusions: Graiii-pos. organisms contributed to the majority 
of CVC-related infections (t 6 out 17 CVC-infections), however, 
overall incidence of CVC-infection in acute leukaemia pts is low 
6,5/100O CVC-days (1,9 proven/2,3 ~uspected/2,3possible/lOOO 
CVC-days) . 
-1 Prediction of gram-negative bacteremia by IL- 
8 serum levels in febrile neutropenic cancer 
patients: targeting empirical combination 
therapy versus monotherapy 
W.V Kern, M. Heiss, A. Engel, L. Bergniann, P Kern, G. 
Steinbach. Uniucrsify Hospifat and Medical Gviter, I h i ,  Gcmnariy 
In a previous study with a 3-times-weekly sanipling protocol we 
found that serum IL-8 levels predicted Gram-negative bx~eremia 
(GNU) in neutropenic cancer patients (pts) with a semitivity of ~ O % I  
and a specificity of 91% and was superior to CRf: IL-6, and procal- 
citonin. We then designed a study with blood sampling at fever onset 
and a decision rule for empirical combination therapy vrrsus 
nionotherapy. Pts with an IL-8 level of 2,000 pg/mL received 
cefepinie (2 g t.1.d.) plus netilmicin (450 mg o.d.), and pts with lower 
IL-8 levels received empirical monotherapy with cefepmie. IL-8 
levels were measured using an automated inimtinoluiiiiiiiscence 
analyzer (Inrnznlite system, DPC-Biermann) allowing single sample 
analysis within 40 min. Evaluahle were 08 pts with 133 febrile 
neutropenic episodes. Most pts had hematologic malignancies. The 
median duration of neutropenia (<500 celldpL) was 13 days. The 
neutropenic fcver was unexplained in 30%, associated with a non- 
pulmonary focal infection in 2694, a pneumonia in 11% and caused 
by bactereniia in 36% (GNB: 15, incl. 3 cases of mixed Gram-nrga- 
tive/Gram-positive bacteremia). There were 1 1  pts with IL-8 levels 
2,000 pg/mL; 8 of them had GNB, yielding a sensitivity of 53% and 
a specificity of 97% (positive predictive value: 73% negative predic- 
tive value: 94%). 4-week all-cause mortality was 11/133 @%I). 5 pts 
died from the presenting infection, 3 of them (2 with GNB) had 1L- 
8 2000 pg/mL at fever onset. Serum IL-8 identifies pts with high- 
risk GNB and helps to target empirical combniation therapy with an 
aniinoglycoside to those who are likely to benefit from it. 
Ip10061 Conventional respiratory viruses recovered 
from immunosuppressed patients. 
N. Rabella', M. Otegui', M. Gurgui', R. Labeaga', M. Herrero', 
J.M. Munoz', G. Prats' . 'Mirvubiology Service, 'Ii!fccfious Discasrc 
Unit, Hospiral Sant Pau, Barcelona, Spain 
Objectives: To review the clinical characteristics and the o u t ~ o n ~ e  
of immunosuppressed patients (IP) from whom a conventional reqpi- 
ratory virus (CRV) was isolated. 
Methods: From January 1991 to December 1995, 785 consecii- 
tive IP with a suspected respiratory tract Infection were studied. All 
specimens were bronchoalveolar lavages (BAL) and were submitted 
for routine aerobic, anaerobic, mycobacterial and fungi culture as well 
as parasite examination. For viral diagnosis, specimens were inoctt- 
lated into each of four cell lines. Medical records of paticnts from 
whom a CRV was isolated were reviewed. 
Results: Of 382 (23%) BAL, 199 viruses were isolated. CMV was 
isolated from 131 (17%) HSV was recovered from 31 (4%) arid 37 
CRV were isolated from 36 patients. CKV included: 11 influenza 
virus, 7 parainfluenza virus, 5 adenoviruc, 5 cnterovirus. 5 respira- 
tory syncytial virus and 3 rhinoviru5. CIiV xcountcd for 19% of all 





virus isolated (20% of viral positive BAL and 5% from all BAL). 
Overall CRV were isolated mainly during the colder months. Seven 
patients (20%) died 3 influenzae virus, 2 adenovirus, 1 parainfluen- 
zae virus and 1 RSV. 
Conclusions: CRV are frequent causes of respiratory illnesses, 
and are associated with high morbidity and mortality in inimuno- 
suppressed patients. Because antiviral therapy may be useful viral 
studies should be performed promptly so therapeutic measures can 
be initiated as soon as possible. 
N Pe Ge S Va Tec 
93 75.3 66,7 73,l 1,l 1,l 
80 33,8 35,0 42,5 0 0 
46 565 69.6 73.9 0 0 
(P10071 Co-existence of CMV, HIV-6 and HHV-7 DNA 
in immunocornprimised patients 
K. Midilli', Z. Baslar', B. Ulgen', S. Ergin', T. Basibiiyiik', T. 
Soysal*, R. Ozturk', B. Ferhanoglu'. Departments of jMicrobiology, 
Hematology, 'Pediatric Hematology, Cerrahpasa School of Medicine, 
Istanbul, Turkey 
Objectives: To determine the co-existence of CMV, HHV-6 and 
HHV-7 DNA in immunocomprimised patients in order to assess any 
relationship between the presence of CMV DNA and DNA of 
HHV-6 and HHV-7. The preliminary results are presented. 
Patients and methods: Sequential secrum and peripheral blood 
leukocytes (PBL) of 15 adult BMT patients and 4 paediatric hema- 
tologic oncology patients and single secrum samples of 17 immuno- 
compromised patients (renal transplant recipients and patients with 
hematologic malignancies) were screened for CMV, HHV-6 and 
HHV-7 DNA by nested PCK. A total of 160 samples (121 serum 
and 39 PBL samples) were tested. 
Results: 28 serum samples belonging to 15 patients and 11 paired 
PBL samples belonging to 9 patients were positive for CMV DNA 
15 serum samples belonging to 9 patients (5 of them were also posi- 
tive for CMV DNA) and 4 PBL samples belonging to 2 patients (both 
were positive CMV DNA) were positive for HHV-6 DNA. In one 
patient the paired serum sample was negative for HHV-6 DNA. 22 
serum samples belonging to 9 patients (6 of them were positive for 
CMV DNA and 4 ofthem were also positive for HHV-6 DNA) were 
positive for HHV-7 DNA. None of PBL samples were found to be 
positive for HHV-7 DNA. One serum sample was positive for HHV- 
6 and HHV-7 DNA. Three patients were only positive for HHV-6 
DNA and 2 patients only for HHV-7 DNA. CMV disease was diag- 
nosed in only three patients (2 BMT and one paediatric patient). One 
BMT patient remained negative for HHV-6 and HHV-7, whereas 
the other BMT patient were positive for only HHV-6. Paediatric 
patient was positive for both of HHV-6 and HHV-7. 
Table: The distribution of positive samples. 
PBL 
Conclusions: N o  relationship was observed between simultaneous 
existence of HHV-6 and HHV-7, and CMV disease and no clinical 
disease due to HHV-6 or HHV-7 was diagnosed. The existence of 
HHV-6 and /or HHV-7 DNA was regarded clinically irrelevant. 
Resistance to antibiotics of Enterococcus 
strains colonizing immunocompromised 
patients 
E. Dworniczek', E. Mrbz', I .  Jaworska', K. Kuzko', A. Lange'. 
'Department of Microbioiogy, Mediral University of Wroclatu, 2BMT Unir 
uf K. Dlusrhi Hospital, Wroclaw, Poland 
Objectives: The purpose of this work was to determine the suscep- 
tibility to antibiotics of Enterococcus strains colonizing immunocom- 
promised patients. 
Methods: Isolates from urine, stool, respiratory tract obtained 
from patients from the BMT Unit of K. Dluski Hospital, were 
collected during the period from 1996 to 1998. Patients were decon- 
taminated with a regimen consisting of ciprofloxacin or neomycin, 
cotrimoxazole, colistin, aniphotericin Band acyclovir. Identification 
of the strains was performed by the AP120 System (bioMkrieux, 
France). Susceptibility testing to penicillin (Pe-IOU), vancomycin 
(Va-30mcg), teicoplanin (Tec-30mcg), gentamicin (Ge-l20nicg), 
streptomycin (S-300mcg) (Becton-Dickinson, USA) was carried out 
by a disc-diffusion assay in accordance with NCCLS recommenda- 
tions. 
Results: In the group of 74 patients, Efaecalis, Efaecium domi- 
nated in the respiratory tract and Ejiecium, Eheralis, E.rassel$avus in 
the intestinal tract. E,faecium and E,faecalir were the main agents of 
UTI. In the group of 226-126 strains (55.8%) were resistant to Pe, 
124 (54.9%) to Ge, 138 (61.1%) to S and l(0.496) to Va and Tec. 
I % of omanism resistant to 
Conclusions: E.$ecium and E,faeca/is were the most dominant 
species colonizing respiratory and digestive tracts. Pe, Ge, S was the 
most frequently observed pattern of resistance. 
lm1 Isolation of a multiresistant Yokenella 
regensburgei strain in an immunosuppressed 
patient 
J. Lopez-Barba, I. Jesus de la Calk, M.A. Rodriguez-Iglesias. 
Laboratory of Microbiology, Puerto Real University, Puerto Real, Spain 
Objectives: Yokenella regensbu~ei s an enterobacteria that has only 
rarely been isolated in humans. It has been recovered fiom several 
anatomical sites including the upper respiratory tract, urine and 
faeces. We present a strain of multi-resistant I.: regensburgei isolated 
from urine in an imniunosuppressed patient. 
Methods: A 53-year-old man, HIV infected (category C3), with 
urethral stenosis and recurrent urinary tract infections was admitted 
because of fever and malaise. A urine specimen was submitted and 
routine chemistry and cytology were done. The sample was cultured 
according to conventional methods and identified by MicroScan 
WalkAway System (Dade Behring) including antibiogram. 
Results: Urine chemistry and cytology were clearly indicative for 
urinary infection. The culture was positive significantly for Gram- 
negative bacilli, oxidase negative, growth on MacConkey Agar and 
was identified as I: regensburgei. This strain showed resistance to ampi- 
cillin, anioxicillin/clavulanate, cefazolin, cephalothin, ciprofloxacin, 
cefuroxime, nitrofurantoin, fosfomicin, gentamicin, norfloxacin, 
pefloxacin, piperacillin, pipemidic acid, trimethoprim/sulfaniethox- 
azole, ticarcillin, tetracyclin and was susceptible to aniikacin, 
tobramycin, cefotaxime, and imipenem. The patient was treated with 
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cefotaxiiiie, showed iniprovement after four days and was discharged 
asymptomatic. 
Conclusions: This is the first description of multi-resistant Y 
r r ~ r r u b n ~ ~ e i .  It is rmiarkable that the patient was prophylactically 
treated over the long-term with pipemidic acid and trimetho- 
prini/sulfaniethoxazole before this outbreak. This demonstrates that 
the uncontrolled use of antibiotics leads to the appearance of resis- 
tance also in organisms that are usually susceptible. 
(p10101 Screening patients with hematologic 
malignancy for pulmonary nocardiosis 
K. Yazan Sertoz, R. Inci, E. Tumbay, S. Cagirgan. Ege University 
LWedical f acu l r~~ ,  Izmir, Etrkey 
Objectives: Patients with immunosuppression are at high risk of 
infection. One of these infections is pulmonary nocardiosis. We 
focused on patients with hematologic malignancy due to illness 
and/or therapy 
Patients and methods: During the interval between October 
1996 and October 1997 we screened 39 patients with hematologic 
malignancy showing symptoms and signs of pneumonia (14 acute 
myelocytic leukemia, 10 Hodgkin lymphoma, 7 acute lyniphocytic 
leukemia, 4 non-Hodgkin lymphoma, 2 niyelodysplastic syndrome 
and 2 multiple myeloma).Sputa from patients were stained with both 
Gram and modified Kinyoun methods and inoculated on to blood 
agar, SLlA and Lowenstein-Jensim media. The cultures were incubated 
at 37°C for three weeks and weekly checked for growth control. 
Results: Growth was detected on the 14th day of the sputum 
culture in only one patient with multiple myeloma. The isolated 
microorganism was identified as Nocardia asteroides sensu stricto 
aker the biochemical and bactt:riological tests. 
Conclusions: Clinicians should also suspect pulmonary nocar- 
diosis in patients with hematologic malignancy showing signs and 
symptoms of pneumonia and should also warn the laboratory when 
sending the Tpecimens. The laboratory should incubate the cultures 
for three weeks in view of slow--growing organisms such as Nocardia. 
ml A study of enzymatic profiles of soil isolates 
of Nocardia asteroides 
T.D. Chugh', Z.U. Khan', R. Chandy', E Provost', F? Iloiron'. 
'Depnrtntent of Microbiology, Faculty ofMedicine, Kuwait University, 
Kuwait; 'National R&rence Cenierfur Human Mycoses, Antgnnpl 
Agents and Acrinonaycetes, Pasteur Institute, Paris, France 
Objectives: To develop alternative methods for rapid identification 
of nocardiae. 
Methods: Using API-ZYM system (bioMerieux, France), we 
have reported enzyme profile of 42 soil strains and 2 clinical strains 
of Norurdia asteroides isolated locally. The system has a gallery of 19 
enzyme substrates and one control. 
Results: Of the 19 enzymes tested, only 7 were demonstrable in 
over 90% of the soil isolates. These included alkaline phosphatase, 
esterase lipase, leucine arylamidase, acid phosphatase, phosphohydro- 
lase, a-glucosidase and 8-glucosidase. In addition, 13-galactosidase 
activity was demonstrated in all the strains by 0-nitrophcnyl -1l-D- 
galactopyranoside test. The enzymes which were not demonstrable 
in 95% of the strains included valine arylaniidase, cystine arylamidase, 
trypsin, chymotrypsiii, (a-galactosidase, R-glucoronidase, N-acetyl- 
R-glucosaminidase, a-mannosidase and a-fucosidase. With the excep- 
tion of valine arylamidase, which was lacking in all but one isolate, 
the enzyme profiles of the soil isolates were comparable with the clin- 
ical isolates of N asternides reported in previos studies. 
Conclusions: The study reinforces the view that specific diffcr- 
ences in the enzymatic profiles of Noiardia species could he used for 
their rapid identification. 
(p10121 Nosocomial Candida kruseifungemia in 
cancer patients -report of 10 cases and 
review 
V Krcmery Jr1,2, S. Spanik'.', A. Kunova', J. T r ~ p l ' ~ ~ .  J. Sufiiartky', 
S. Grausova*. 'Xatiowul ond St Elisabrth Cuncrr Iirstirirtrs. Bmtislaim, 
'Department ofMedirine,  School of Ptiblic Health, L'niivrsity cf Pnava, 
Trnalq Slovak Kepubiic 
Teii cases of fungaemia due to Caridida knrsrt, appearing last 1 0  years 
in a single national cancer institution arc analyzed for ri\k factors, 
therapy and autconie. Univariate analyses did not find any cpecific 
risk factors in comparison to 51 C. albirnws fungaeniias appearing at 
the same institution and similar antibiotic policy. Association with 
prior prophylaxi? with flucoiiazole wa? not confirmed. Howcwcr, 
attributable and crude mortality due to C. knrsei fungarmias were 
significantly higher (40 % vs 15,7 'X) p<0,00 1 and 30 '% v\ 9,s '%) 
p<0,045) in comparison to C. albiians. Review of 14X C. kntsci 
fungaemias published within last 10 years is attached to conipnrr inci- 
dence, therapy and outcome with C. krusei fungaemia from our 
cancer institute. 
Fungemia in patients with solid tumors 
V Krcmery Jr, S. Grausova, J. Trupl, S. Spanik, A. Kunova. 
National and St ElisaOetlt Cancer Institutes, Bratislava; Departnient of 
Pharmacology, k~icrobiology, Oncokyy, Ufiivrrsity sf Trwnvn, Enaun, 
Slovak Republic 
During the last 10 years( 1988-1997 ), in our 2 nidjoi- national cdncer 
institutions ( National and St. Elisabeth cancer institutes ) fungacniia 
appeared in 62 patients with solid tuniors without BMT or stream 
cell transplantation . In 35 (56,5%), fungaeinia was due to C. allncarrr. 
in 24 (38,7%) due to noti- albicunr Candida spp. ( C. krnsri, C. tropi- 
calis, C. parupsilosis.C.stellatoidea. C. glabrata), and only in 3 due to tm- 
Candida rpp, yeasts (4,8%) attributable mortality (death due to 
fungaeniia) was 18% and crude mortality (death with fungaeiiiia 
ll,S%). Major risk factor5 for development of fhgaemia in patients 
with ST were (i) prior therapy with antibiotics (8S,2'%) and (ii) vascu- 
lar catheter insertion (91,8%). When comparing risk factors, etiol- 
ogy and outcome in fungaemia appearing within the same period in 
patients with acute leukemia (22 patients, AL group) or 1vmphom.i 
(17% patients, LY group), we found several risk factor 
associated with fungaemia in patients with S T  (i) niiic 
in AL, p<0,001, 41,2%) in LY, p<O,OO?) but only 1,694 in patients 
with ST, (ii)previous therapy with corticosteroidcc (50% in AL, 
p<0,0005, 64,7%, in LY p<O,O01) and only 1 1,5'% in ST, (iii) 
neutropenia (100% in AL, p<O,OO1, 82,3'% p<O,OOI in LY but only 
22,5%9 in ST) (iv) prophylaxi5 with quinolones (IOO%, in AL, 
p<O,OOI, 47,1'% in LY, p<O,OO1 but only 8,1% in  ST, and (v) break- 
through fungaemia during antifungal prophylaxis (86,4% in  AL : 
p<O,OOl, 64,7% in LY p<0,003 but only 22,9 '% in ST were more 
frequently observed in fungaemia in patients with AL and LY, than 
in patients with ST. Vice versa, C. albicans etiology (56.5% vs 22,7'% 
in AL, p<O,OI ) was significantly more .frequently observed among 
ST in comparison to AL, however the incidence of C. nibiianr was 
similar to patients with LY. Patients with AL were more frequently 
infected with both Non- Candida spp. I+nsts (Trichosporon spp., 
Cryptococcus spp.) (45,5% in AL and 43%) in ST, p<O,OOl) or molds 
(13,6% in AL vs 0%) ST, p<O,002). There w a ~  also difference in 
358 C l in ica l  M i c r o b i o l o g y  and  In fec t i on ,  Vo lume 5 Supp lement  3 
attributable mortality, which was lower in ST that in AL (18% vs 
40,0%, p<0,05) but similar to those suffering from LY In conclu- 
sion, several risk factors associated with intensive cytotoxic 
chemotherapy (neutropenia, prophylaxis with with quinolones, 
azoles, mucositis) were logically less frequently observed in patients 
with ST was fungaemias. Also etiology of fungaemia in patients with 
ST was different (more C. albicans and less Non-Candida spp. and 
molds). Attributable mortality of fungaemias in ST was lower in 
comparison to fungaemias in AL. 
m] Reduced T-helper-cell counts and risk for 
Pneumocystis carinii pneumonia (PCP) in 
patients receiving immunosuppressive 
therapy 
T. Check’, H.F. Geerdes-Fenge’, H. Lode2, J. Schoelmerich’ 
‘ UKL-Regensburg, Regmsburp, ’Lunfenklinik Heckeshorn, Berlin, 
Gerwrany 
Objectives: To define predictive parameters for Opportunistic infec- 
tions in HIV-negative patients receiving immunosuppressive therapy. 
Methods: In 7 patients with confirmed PCP and in 70 patients 
without opportunistic infections, who all received immunosuppres- 
sive therapy with corticosteroids and/or methothexate, azathioprine, 
or cyclophospbarnide. CD4+ and CD8+ T-lymphocyte counts 
were determined by FACS-analysis. All patients were HIV-negative. 
The vast majority of patients suffered from rheumatic diseases. 
Results: At the time of PCP diagnosis, all 7 patients with PCP 
received prednisolone 10 nig qd and 6 out of 7 patients other 
immunosuppressive drugs. Their CD4+ T-cell-counts were less than 
2OO/p1 (20-182, mean 9O/pl). In the patients who received 
imniunosuppressive therapy and did not develop PCP, only 26% had 
CD4+ T-cell-counts of less than ZOO/$ (40-941, mean 351/pI, 
p=0.002). Patients who received corticosteroids 10 mg prednisolone 
qd in addition to other imniunosuppressive drugs had lower CD4- 
counts than those who took corticosteroids < = lOmg qd (261 vs. 
372/pI, p=0.05), and also a higher percentage of CD4+ T-cells 
<200/pl (42 vs 23%). Patients receiving corticosteroids and 
cyclophosphamide had lowest CD4+ T-cekounts  (mean: 125/pl) 
CD4/8 ratio and percentage of CD4+ lymphocytes did not differ 
between the patient groups and normal controls. 
Conclusions: Immunosuppression may lead to lymphopenia 
with a severe T-Hel-per-cell deficiency, similar to advanced HIV- 
infection. Patients receiving immunosuppressive therapy are at risk 
for PCP (and other opportunistic infections?) if their regimen consists 
of corticosteroids 10 mg of prednisolone qd combined with other 
immunosuppressive drugs, and if their CD4+ T-cells are <200/pl. 
m] Pneumococcal vaccine use in splenectomized 
patients at a Swiss tertiary care center 
between1973and1995 
M. Felder, K. Miihlemann, A. Vogt, A. Cerny. Dept. Innere 
Medizin. Insekpital, Bern, Switzerland 
Objectives: To assess the use of pneumococcal vaccine in patients 
undergoing splenectomy for any indication between 1973-95 at the 
University Hospital of Bern , and to offer vaccination. 
Methods: Data on patients with splenectomy were obtained from 
hospital statistics, clinical charts, and a mailed questionnaire. Patients 
who had been vaccinated never or 6 years ago were offered 23-dent  
pneumococcal vaccine (Pneumovax). 
Results: O f  789 splenectomised patients 247 (31.3%) had been 
vaccinated during hospitalisation and 49 (6.2%) were discharged with 
a vaccine recommendation. A letter was sent to 456 patients who 
were still alive and qualified for a vaccine (i.e. never vaccinated or 
vaccination status unknown (n=347), vaccinated 6 years ago 
(n=113)). O f  them we have vaccinated 156 (67.7%) patients. 
Conclusions: Pneumococcal vaccine is greatly underused in high 
risk patients undergoing splenectomy in Switzerland. A large nuniber 
of splenectomized patients are at risk of developing invasive pneu- 
mococcal infections. This look back study allowed to offer vaccine 
to a considerable number of patients. 
ml Symmetrical peripheral gangrene after S. 
pneumoniae infection in a post-splenectomy 
patient 
L. Comerford, J. Gregoire, G. Poland. h fayo  Clinic and Foundation, 
Rochester, &IN, U S A  
Strepforoccirs pneumoniae is a vaccine-preventable virulent pathogen 
which causes significant morbidity and mortality with up to 570,000 
cases of pneumonia, 5U,OOO cases of bacteremia, and 40,000 deaths 
each year in the United States alone. Especially vulnerable are the 
elderly, chronically ill, and immunocompromised individuals, includ- 
ing those with asplenia. Rarely, S. pneurnoriiae sepsis causes a clinical 
finding called symmetrical peripheral gangrene (SPG). SPG is 
ischemic necrosis of the distal portions of two or more extremities 
despite a patent proximal arterial supply. We describe the first k n o w .  
case of gangrene in all four extremities resulting from S. pneumoniae 
sepsis in the setting of prior splenectomy. The patient was a 34-year 
old female who had a splenectomy in 1983 afrer trauma. She report- 
edly received the 14-valent pneumococcal vaccine at that time but 
never received the 23-valent vaccine or a follow-up booster. She 
presented with a five day history of fever, headache, cough, arthral- 
gias. and burning sensations in her lower extremities. Mottling of her 
skin was noted, progressing from the feet to the waist and from the 
hands to the elbows. She recovered, but eventually required bilateral 
below-the-knee and below-the-elbow amputations. Because the 23- 
valent vaccine includes 390% of the pneumococci serotypes causing 
bacteremia, we speculate that had this patient been re-vaccinated 
with the 23-serotype vaccine, she may not have developed this 
complication. The percent of high-risk patients <65 years of age 
who are adequately iinmunized against S. pneumoniae is < 10% The 
latest recommendation in the U. S. is that all splenectomized patients 
receive the 23 serotype pneumococcal vaccine, with a “booster” dose 
5 years later. Patients who received the older 14-valent pneumococ- 
cal vaccine (before 1984) should have their vaccine updated. This is 
an especially important consideration for asplenics. 
Ip10171 Cefepime plasma concentrations in patients 
with severe febrile neutropenia treated by a 
continuous infusion of 4 g daily 
L. Noens, E Verbeeck, A. Janssens, E Offner, W. Van Hove 
Hematology, LJniuersity Hospital Cent, Gent, Belgium 
Rationale: Betalactam antibiotics are widely used in this setting, 
frequently associated with aminoglycosides. Based on their antimi- 
crobial action, they are best administered in a continuous infusion. 
Cefepim compares favorably to other cephalosporins based on its 
antimicrobial spectrum of action and on its stability in infusions. We 
examined the plasma concentrations of cefepim to determine the 
steady state level during infusion of 4 grams daily in neutropenics. 
Patients: 12 consecutive haeniatological patients with neutrope- 
nia below loo/$ and untreated fever, detected during hospitalisa- 
tion. 
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Methods: Plasma saiiiples were drawn before, and at 1,4,12,24,48 
and 72 hours after a bolus loading dose of 2 grams, immediately 
followed by the daily 4 gram in saline continuous administration. The 
drug assay method is based on chromatographic separation and spec- 
trophotoinetric detection withh cefazolin as internal standard. 
Results: to tl t4 t i2  t24 t48 t72 
mean:pg/ml 0 57.5 27.2 19.1 18.3 17.2 18.3 
St.dev.: 0 30.8 17.9 12.3 12.4 11.3 12.3 
Conclusions: During treatment of severely compromised patients 
the steady state level reaches the computermodel predicted 19pg/nll. 
This concentration exceeds 3-4 times the MICs of most pathogens. 
Ip10181 Cefepime dose reduction in the treatment of 
febrile neutropenic patients (FNP) 
K. Raniphal, S. Smith, J. Lynch, E Weeks, J.R. Wingard. 
Department of Mediciize, University o f  Florida and Pharmacy Services, 
Sliarid.7 Hospital, Gainesville, FL, USA 
The efficacy of dose reduction in FNP using cefepime was exam- 
ined. AU consecutive hospitalized FNP received 2 grams of cefepime 
every 8 hr at the onset offever, except in renal dysfunction. The dose 
was reduced to 1 gram (a) if ~ d t u r e s  were negative after 48 hr of 
treatment and (b) when the patient became afebrile in niicrobiolog- 
ically or clinically documented infections. I? aernginosa infections 
were continued on 2 grams. Physicians could modify therapy as clin- 
ically indicated. To date 120 patients have been treated. (70% trans- 
plants or leukemics) The mean and median periods of neutropenia 
were 10 and 9 days The mean pretherapy neutrophil count was 70 
cells/cu.mm. 22% bacteremias, 4% had documented infections in 
other sites and the rest were culture negative. 27 gram negative (22 
bacteremias) and 12 gram posii:ive organisms were isolated prether- 
apy. Following reduction 6 patients had bacteremia with gram posi- 
tives that were normally betalactam resistant. N o  enteric or fungal 
superinfections were diagnosed. One presumed culture negative 
infectious death occurred. The mean number ofdays on 2 and 1 gram 
doses was 3.5 and 4.7 for transplants and leukemias. Vanconiycin, 
amiiioglycosides and imipeneni were added in 33, 20 and 2% of 
patients respectively. Compared to the previous 8 months, there were 
significant reductions in doses #of vancomycin (23%) and imipeneni 
(70%) used per month. We colnclude dose reduction, is eficacious 
(infectious mortality 0.8%) even in severely neutropenic patients such 
as bone marrow transplants and leukemics. This prospective observa- 
tional xudy continues to test this strategy of dose reduction. 
m] Efficacy of continuous infusion of ceftazidime 
for patients with neutropenic fever after high- 
dose chemotherapy (HDCT) and stem cell 
transplantation (ABSCT) 
G. Egerer, H. Goldschmidt, U. Hegenbart, R. Haas, A.D. Ho. 
Department cf flrifemal Medicine, University qf Heidelbep, Heidelbq, 
Germ t i  y 
Objectives: Within our efforts to develop an out-patient transplant 
program we have assessed the safety and eficacy of continuous infu- 
sion of ceftazidime in neutropenic patients after HDCT and ABSCT. 
Materials and methods: F'rom 9/95 to 9/98 56 patients with 
febrile neutropenia received a ;! g intravenous bolus of ceftazidinie 
followed by a 4 g continuous-infusiori per 24 hours of ceftazidime 
using a portable infusion pump (Walknied-Puinpc, Logonied, 
Germany). If the fever failed to resolve after 72 hourc, teicoplanin 
(400 nig/day) or vancoinycine (2 x 1 g/day) was added. 
Patient characteristics: Age: median 44 yearc (range 17-62), 
Diagnosis: inultiple myeloma: n=21, breast cancer: n =29, sciiii- 
noma: n=5, Hodgkin's lymphoma: n= 1. Days of neutrophils 
<0,5p1; median 11 (range 7-62) 
Results: 37/56 patients (66%) responded to the monotherapy 
with ceftazidinie. After addition of glycopeptids, further 12 patients 
(21%) became afebrile. The causes of fever were: septicemia in 9 
patients (gram positive bacteria n=7, gram negative bacteria n=2), 
pneunionia in 1 patient, fever of unknown origin in 46 patients. N o  
premature stop of the continuous infusion caused by the infusion 
punip was necessary. 
Conclusions: With daily follow-up and close monitoring it is safe 
and efficacious to administer continuous i.v. antiblotic using a 
portable infusion pump in patients with febrile rieutropenia Liter 
HDCT and ABSCT. 
[p1020) Treatment of 376 episodes of febrile 
neutropenia (FN) with ceftriaxone 
monotherapy-analysis of risk factors 
M. Karthaus', G. Egerer2, T. SiidhoP, 11. Karnpfe', G. Heil', H. 
Jiirgens". 'Department of Hematolopy, Hannover Mediral Sckool, ?Mcd. 
Unw Klinik Heidelbuy, ' & f e d .  Univ. Kliriik Diisse/dotJ "KKH 
Ludenscheid, 5Department o f  Pediatric Hematoloyx Urtiwrsity ( fMunster ,  
Germany 
Objectives: A combination of broad-spectrum antibiotics is reconi- 
mended in FN. Antibiotic monotherapy for FN is discucsed contro- 
versially. We analysed risk factors and eficacy of ceftriaxone 
monotherapy in FN. 
Methods: In a prospective study we analysed 959 febrile eps. from 
48 hospitals between 2/92 and 1/96. Inclusion criteria: neutropenia 
(ANC <1000/& with fever (38.5'C) or CKP 1 nig/dl and 
suspected inkction. 901 eps (acute leukaeniia n=396, lymphonia 
n=220, solid tumours n=272, others n=13) with 828 pts aged 
between one and 97 years were analysed, of which 876 eps. were 
evaluable for response. All pts. initially underwent empirical ceftri- 
axone treatment (adults: 2 g/day; children: 80 iiig/kg/day), either 
alone (n=376) or in combination witti other agents (n=525). 
Results: Mean ANC was 423/p1 (SD +316), median duration of 
neutropenia 10 days. Of 376 eps. treated initially with ceftriaxone 
alone, 70.8% responded vs. 56.9% in the conibinatioii therapy group. 
The favourable response to the initial monotherapy treatment w.is 
achieved within a low-risk population. A low risk was associated with 
a KI 6 (p<0.0001), ANC 500/p1 (p=O.OOOl) and a duration ofANC 
<5  days (p<0.05) which were significantly frequent in the 
monotherapy arm. Concerning a lower risk there were only these 3 
predictive parameters at commencement of treatment. Mortality of 
FN with monotherapy was low (l,l%) and contributed to MLll in 
one eps only (coag.-neg staphylococci) 
Conclusions: Ceftriaxone alone was safe and effective in low ri5k 
FN with a K1 6, an ANC 500/pl, and a duration of ANC <S days 
at comiiiencenieiit of treatment 
